Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

The Cancer Genome Atlas (TCGA) stomach adenocarcinoma analysis

QC Qinbo Cai
WZ Wen Zhou
JL Jin Li
XO Xinde Ou
CC Chuangqi Chen
SC Shirong Cai
WH Weiling He
JX Jianbo Xu
YH Yulong He
request Request a Protocol
ask Ask a question
Favorite

We downloaded mRNA expression data and clinical information of the TCGA stomach adenocarcinoma program from cBioPortal. Patients with stage I-III gastric adenocarcinoma were included. Exclusion criteria as follows: Patients with preoperative chemotherapy or radiotherapy, or with other malignant tumor. Patients with CEA cell adhesion molecule 5 (CEACAM5, name of gene encoding protein CEA) expression in the top 20% range were divided into high expression group, and the rest 80% were divided into low expression group.

Copyright and License information:  ©2021-01-01 The author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A